News | Latest Breaking News Stories & Headlines

The Pfizer vaccine, which it co-developed with Germany's BioNTech, generated $3.5 billion in revenue in the first quarter

Pfizer lifts sales forecast for Covid vaccine to $26bn

Pfizer has forecast $26 billion in Covid-19 vaccine sales this year, a more than 70% jump from its last projection, reflecting new contracts with governments around the world trying to halt the pandemic through rapid vaccination.

Business • 04 May 21

It's not clear what vaccine supplier will be involved

EU looks to secure 1.8bn 2nd-generation vaccine doses

The EU is about to start negotiations with a single pharmaceutical company to secure up to 1.8 billion doses of a "second generation" mRNA vaccine to combat future variants, a European Commission source said.

Coronavirus • 09 Apr 21

The firms have also started testing their Covid-19 vaccine on healthy pregnant women

Pfizer, BioNTech say jab can stand warmer temperatures

BioNTech and its US partner Pfizer have said tests have shown that their Covid-19 vaccine can stand warmer temperatures than initially thought, potentially simplifying the jab's complex cold-chain logistics.

Coronavirus • 19 Feb 21

The EU commission now has access to a vaccine portfolio of 2.6 billion doses

EU buys up to 300 million more Moderna jabs

The European Commission has said it had struck a deal for an extra 150 million doses of Moderna's Covid-19 vaccine this year, nearly doubling the number of shots secured from the US biotech firm for 2021.

World • 17 Feb 21

Pfizer is trying to deliver two billion doses of its Covid-19 vaccine this year

Pfizer sees $15 billion in 2021 sales from vaccine

Pfizer said today that it expected to generate $15 billion, or about a quarter of its total revenue this year, from the sale of its Covid-19 vaccine that it has developed with German partner BioNTech.

Business • 02 Feb 21

The reduction will affect all European countries, the Norwegian Institute of Public Health (FHI) has said

Pfizer delay to have 'modest' impact on vaccine rollout

The Head of the Covid-19 National Vaccine Taskforce has said there will only be a modest impact to the rollout of the vaccination programme by a temporary reduction in supplies of the Pfizer BioNTech vaccine.

Coronavirus • 15 Jan 21

Professor Karina Butler said the AstraZeneca vaccine would allow easier rollout at a community level

EMA may approve AstraZeneca vaccine by end of month

Europe's medicines regulator has said it expects drug maker AstraZeneca to apply for approval of its Covid-19 vaccine next week.

Coronavirus • 08 Jan 21

The BioNTech-Pfizer vaccine has been delivered in less than a year

From the lab to the jab: The BioNTech-Pfizer vaccine

It was over breakfast on the wintry morning of 24 January that Ozlem Tureci and her husband Ugur Sahin decided, "we need to fire the starting gun on this".

Coronavirus • 26 Dec 20

A phial of the Pfizer/BioNTech Covid-19 vaccine

US FDA staff back Pfizer's coronavirus vaccine data

Pfizer has cleared the next hurdle in the race to get its Covid-19 vaccine approved for emergency use after the US Food and Drug Administration released documents that raised no new issues about its safety or efficacy.

Coronavirus • 08 Dec 20

Effective immunisation is seen as the main weapon against the pandemic (stock image)

Cabinet approves purchase of Moderna Covid vaccine

The Cabinet has approved an advance purchase agreement for 875,000 doses of the Covid-19 vaccine produced by Moderna.

Coronavirus • 01 Dec 20

Pfizer/BioNTech to seek emergency approval for vaccine

Pfizer and its partner BioNTech confirmed they will apply for emergency use authorisation for their coronavirus vaccine, becoming the first to do so in the US or Europe as the pandemic rages around the world.

Coronavirus • 20 Nov 20

Vaccine was developed with German partner BioNTech

Pfizer ends Covid-19 trial with 95% efficacy

Pfizer has said that final results from the late-stage trial of its Covid-19 vaccine show it is 95% effective, adding it had the required two months of safety data and would apply for emergency US authorisation within days.

Coronavirus • 18 Nov 20

Warren Buffett normally handles large investments for Berkshire's $245.3 billion stock portfolio himself

Buffett's Berkshire bets on Big Pharma

Warren Buffett's Berkshire Hathaway said it has begun investing in the stocks of four large drugmakers, betting on an industry that could benefit when the world begins emerging from the coronavirus pandemic.

Business • 17 Nov 20

About a dozen Covid-19 vaccines around the world are currently in the final stages of testing

What progress is being made with Covid-19 vaccines?

Here is everything you need to know about the coronavirus vaccine race.

Coronavirus • 09 Nov 20

Pfizer and German partner BioNTech SE are the first drug-makers to show successful data from a large-scale clinical trial of a coronavirus vaccine

Medical experts cautiously optimistic over vaccine news

There has been a cautiously optimistic reaction from medical experts after Pfizer said its experimental vaccine was more than 90% effective in preventing Covid-19 based on initial data from a large study.

News Lens • 09 Nov 20

European stock markets are soaring today on Pfizer's coronavirus vaccine hopes

World markets soar on coronavirus vaccine hopes

World stock markets soared today on hopes of a coronavirus vaccine following successful trials by pharmaceutical company, Pfizer.

Business • 09 Nov 20

Pfizer plans to build a development facility on its existing Ringaskiddy site in Co Cork

Pfizer to create 300 jobs in Dublin, Kildare and Cork

Pfizer is creating about 300 new jobs at its manufacturing sites in Grange Castle in Co Dublin, Newbridge in Co Kildare and Ringaskiddy in Co Cork.

Business • 02 Nov 20

Pfizer hopes to be the first US drugmaker to unveil successful data from a late-stage Covid-19 vaccine trial

Pfizer not yet ready to release Covid-19 vaccine data

Drugmaker Pfizer said today it was not yet ready to release data from the late-stage trial of the Covid-19 vaccine it is developing with Germany's BioNTech.

Business • 27 Oct 20

The European Commission in talks with BioNTech-Pfizer to buy up to 300 million doses of a potential vaccine against Covid-19

EU enters final talks for BioNTech-Pfizer vaccine

The European Commission said today it had entered final stage talks with BioNTech-Pfizer to purchase up to 300 million doses of a potential vaccine against Covid-19.

Business • 09 Sep 20

Pfizer has taken a roughly $500m hit to sales due to a drop in visits to hospital or the doctor's office due to Covid-19

Pfizer raises forecast despite Covid-19 impact

Pfizer has today beaten analysts' estimates for second-quarter profit and raised its full-year earnings forecast.

Business • 28 Jul 20

Moderna, Pfizer start decisive Covid-19 vaccine trials

Pfizer and Moderna have launched two 30,000-subject trials of Covid-19 vaccines that could clear the way for regulatory approval and widespread use by the end of this year.

Business • 28 Jul 20

Pfizer and Germany's BioNTech are among a handful of companies racing to develop a safe and effective vaccine for Covid-19

US to pay Pfizer $1.95 billion for Covid-19 vaccines

Pfizer and German biotech firm BioNTech will get $1.95 billion from the US government to produce and deliver 100 million doses of their Covud-19 vaccine candidate, the companies said today.

Business • 22 Jul 20

The drug is one of 17 being tested on humans in a frantic global race to find a vaccine

BioNTech and Pfizer's Covid-19 vaccine shows potential

A Covid-19 vaccine developed by German biotech firm BioNTech and US pharmaceutical giant Pfizer has shown potential and was found to be well tolerated in early-stage human trials, the companies said today.

Business • 01 Jul 20

Sanofi expects to get approval for the potential Covid-19 vaccine it is developing with GlaxoSmithKline by the first half of next year

Sanofi eyes approval of Covid-19 vaccine by H1 2021

French drugmaker Sanofi said today it expects to get approval for the potential Covid-19 vaccine it is developing with Britain's GlaxoSmithKline by the first half of next year, faster than previously anticipated.

Business • 23 Jun 20

Pfizer is among the many drugmakers in the race to develop a vaccine to end the Covid-19 pandemic

Pfizer sticks to forecast after Q1 profit boost

Pfizer has today reiterated its 2020 forecast after posting a quarterly profit that exceeded estimates on higher sales of breast cancer drug Ibrance and blood thinner Eliquis.

Business • 28 Apr 20